Testing effectiveness (Phase 2)Study completedNCT00669019
What this trial is testing
Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
Who this might be right for
Recurrent MelanomaStage IIA MelanomaStage IIB Melanoma+2 more
National Cancer Institute (NCI) 23